Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients.
Satoh
Noriko
N
Clinical Research Institute for Endocrine Metabolic Disease, Kyoto Medical Center, Japan.
Naruse
Mitsuhide
M
Usui
Takeshi
T
Tagami
Tetsuya
T
Suganami
Takayoshi
T
Yamada
Kazunori
K
Kuzuya
Hideshi
H
Shimatsu
Akira
A
Ogawa
Yoshihiro
Y
D052242:Adiponectin; D000367:Age Factors; D001161:Arteriosclerosis / Q000209:etiology* / Q000517:prevention & control; D015415:Biomarkers / Q000032:analysis; D001823:Body Composition; D015992:Body Mass Index; D015331:Cohort Studies; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000175:diagnosis*; D005260:Female; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000032:analysis / Q000378:metabolism*; D020738:Leptin / Q000032:analysis / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000175:diagnosis*; D011336:Probability; D011379:Prognosis; D011446:Prospective Studies; D012016:Reference Values; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D012737:Sex Factors
D052242:Adiponectin; D015415:Biomarkers; D036341:Intercellular Signaling Peptides and Proteins; D020738:Leptin